Mapping Treatment Advances in the Neurobiology of Binge Eating Disorder: A Concept Paper
Brooke Donnelly, Phillipa Hay

TL;DR
This concept paper explores how advances in understanding the brain and body can lead to better treatments for binge eating disorder.
Contribution
The paper introduces the microbiota-gut-brain axis as a novel therapeutic strategy for binge eating disorder.
Findings
Neurobiological abnormalities in reward and self-regulation are key targets for BED treatment.
The microbiota-gut-brain axis may influence BED pathogenesis and treatment strategies.
Abstract
Binge eating disorder (BED) is a complex and heritable mental health disorder, with genetic, neurobiological, neuroendocrinological, environmental and developmental factors all demonstrated to contribute to the aetiology of this illness. Although psychotherapy is the gold standard for treating BED, a significant subgroup of those treated do not recover. Neurobiological research highlights aberrances in neural regions associated with reward processing, emotion processing, self-regulation and executive function processes, which are clear therapeutic targets for future treatment frameworks. Evidence is emerging of the microbiota-gut-brain axis, which may mediate energy balance, high-lighting a possible underlying pathogenesis factor of BED, and provides a potential therapeutic strategy.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEating Disorders and Behaviors · Obsessive-Compulsive Spectrum Disorders · Tryptophan and brain disorders
